(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of -9.49% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Precision Biosciences's revenue in 2024 is $48,727,000.On average, 2 Wall Street analysts forecast DTIL's revenue for 2024 to be $208,178,794, with the lowest DTIL revenue forecast at $138,324,780, and the highest DTIL revenue forecast at $278,032,808. On average, 2 Wall Street analysts forecast DTIL's revenue for 2025 to be $192,271,444, with the lowest DTIL revenue forecast at $69,162,390, and the highest DTIL revenue forecast at $315,380,498.
In 2026, DTIL is forecast to generate $264,546,142 in revenue, with the lowest revenue forecast at $69,162,390 and the highest revenue forecast at $459,929,894.